消息面上，Vir Biotechnology第四季度营收为6407万美元，同比增长417%，市场预期为4416万美元；每股亏损0.31美元，去年同期每股亏损0.76美元。此外，公司宣布VIR-5500的1期临床试验中取得积极结果，VIR-5500是一种用于治疗晚期转移性去势抵抗性前列腺癌的在研疗法。 (格隆汇) ...

西雅图 - Nautilus Biotechnology, Inc. (NASDAQ:NAUT)今日宣布任命Amber ...

Investing.com -- MAIA Biotechnology 股价在周二盘前交易中下跌29%至$1.47,此前这家药物开发商宣布以大幅折价进行3000万美元的公开发行。

在今日的股市交易中，Vir Biotechnology (VIR.US) 的股价表现引人注目，最高涨幅超过38%，触及10.29美元，创下逾一年以来的新高。这一涨幅的主要驱动力来自于公司发布的第四季度财报，其营收为6407万美元，同比大幅增长417%，超出市场预期的4416万美元。此外，每股亏损改善至0.31美元，相较于去年同期的0.76美元显著好转，显示出公司在财务上的积极变化。

Puma Biotechnology (NASDAQ:PBYI) reported fourth-quarter 2025 total revenue of $75.5 million, driven by NERLYNX product ...

Anbio Biotechnology continues pivoting toward better profitability metrics, prioritized high-margin orders over sales volume.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Experts discuss biotechnology's role in advancing personalized medicine at a VIT webinar, highlighting career opportunities ...

Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor ...

Detailed price information for Pds Biotechnology Corp (PDSB-Q) from The Globe and Mail including charting and trades.

The Department of Biotechnology, under the Ministry of Science and Technology has released notification for the Scientist 'C' posts.